Insight Molecular Diagnostics
Business Services · Tennessee, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 International Plz Ste 510, Nashville, ...Phone Number
(615) 255-8880Website
www.imdxinc.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Insight Molecular Diagnostics
iMDx specializes in precision diagnostics for oncology and transplantation, providing innovative solutions that cater to the needs of researchers, clinicians, and healthcare systems. Their product offerings include molecular diagnostic tools designed for early detection, treatment guidance, and research applications. The company is committed to advancing precision medicine and improving patient outcomes through actionable insights and scalable diagnostic solutions. iMDx aims to democratize access to molecular diagnostic testing, creating sustainable value for healthcare providers and patients alike.Explore more
Insight Molecular Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Insight Molecular Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Insight Molecular Diagnostics has new funding data
Earning: See what the market has to say on Insight Molecular Diagnostics recently announced quarterly report
Click to see if Insight Molecular Diagnostics had a recent Job posting/layoffs
Product Launch: Get notified when Insight Molecular Diagnostics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Insight Molecular Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Insight Molecular Diagnostics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Insight Molecular Diagnostics
Website visits: Recent activity has been detected on your website
Check if Insight Molecular Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Insight Molecular Diagnostics
Find more new buyers
Company Profile Activity
Activity Insights
Insight Molecular Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Insight Molecular Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Insight Molecular Diagnostics.
Insight Molecular Diagnostics Tech Stack
A closer look at the technologies used by Insight Molecular Diagnostics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Earnings
continues to target an average cash burn of about $6 million per quarter until its commercial launch next year, with expectations of higher burn in Q3 before coming back down in Q4. The company noted that the biggest factors affecting cash management are its clinical trial and the purchase of discounted instruments to support the trial at partner sites.
Earnings, Financial Planning, Business Finance, Finance, Financial Strategy
Earnings
reported sales of $24,000 worth of first-generation Raft Assured IQ kits in Q2. The company began shipping second-generation kits to customers in June, with initial kits provided as free samples for lab validation.
Earnings, Product Launch, Finance, Healthcare Technology
Earnings
Earnings, Accounting, Financial Reporting, Business Finance, Finance
Insight Molecular Diagnostics News & Media
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company's GraftAssure platform, which leverages digital PCR technology to deliver reliableInsight Molecular Diagnostics Inc. (IMDX) Q2 2026 Earnings Call Transcript
Insight Molecular Diagnostics Inc. (IMDX) Q2 2026 Earnings Call August 10, 2026 5:00 PM EDTCompany ParticipantsGabrielle Woody - Sr.IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
NASHVILLE, Tenn., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its first quarter results:iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
NASHVILLE, Tenn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. iMDx will host a live Zoom webinar to discuss the company's financial results at 2:00 pm PT / 5:00 pm ET that same day.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Insight Molecular Diagnostics
Sign Up For FreeTo access detailed company insights
iMDx specializes in precision diagnostics for oncology and transplantation, providing innovative solutions that cater to the needs of researchers, clinicians, and healthcare systems. Their product offerings include molecular diagnostic tools designed for early detection, treatment guidance, and research applications. The company is committed to adv... Read More
